Tender Details

Country: Japan
Summary: Infliximab Bs for I. V. Infusion 100Mg (1Vial) 316 Cases,Biktarvy Combination Tab. (30 Tablets 1Bottle) 65 Cases,Humira 40 Pen 0.4Ml (1Kit) 218 Cases
JPT Ref No: 49415954
Deadline: 16 Mar 2021
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.:
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
①Infliximab BS for I. V. Infusion 100mg (1vial) 316 cases,②BIKTARVY Combination Tab. (30 tablets 1bottle) 65 cases,③HUMIRA 40㎎ pen 0.4ml (1kit) 218 cases
Classification :
0004 Medical & Pharmaceutical Products
Summay of Notice :
⑴ Official in charge of a disbursement of the procuring entity : Hideaki Isohata, Director of Accounting Department, Self Defense Forces Central Hospital
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
① Infliximab BS for I. V. Infusion 100mg (1vial) 316 cases
② BIKTARVY Combination Tab. (30 tablets 1bottle) 65 cases
③ HUMIRA 40㎎ pen 0.4ml (1kit) 218 cases
Provided that the quantity is a temporary estimate at the present time, and it is subject to be changed
⑷ Derivery Period : from 1, April 2021 to 31, March 2022
⑸ Delivery Place : Self Defense Forces Central Hospital
⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
① Not come under Article 70 of the Cabinet Order concerning the Budget, Auditing and Accounting. Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause.
② Not come under Article 71 of the Cabinet Order concerning the Budget, Auditing and Accoun...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Infliximab Bs for I. V. Infusion 100Mg (1Vial) 316 Cases,Biktarvy Combination Tab. (30 Tablets 1Bottle) 65 Cases,Humira 40 Pen 0.4Ml (1Kit) 218 Cases - Japan Tender

The MINISTRY OF DEFENSE, a Government sector organization in Japan, has announced a new tender for Infliximab Bs for I. V. Infusion 100Mg (1Vial) 316 Cases,Biktarvy Combination Tab. (30 Tablets 1Bottle) 65 Cases,Humira 40 Pen 0.4Ml (1Kit) 218 Cases. This tender is published on JapanTenders under JPT Ref No: 49415954 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-03-16.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.